Skip to the main content.

Cell and Gene Therapy Series. Part 2

Dr. Dave Seaward : 20 January 2022

Cell and Gene Therapy Series. Part 2

PDF File: Cell and Gene Therapy: What are ATMPs and why do they matter?

Welcome to part 2 of our Cell and Gene blog series. Click the pdf link above to access the second blog.

This second blog provides a primer to 'ATMPs', looking at what they are why they matter. The reader will get an insight into some of the historical context and various technologies behind ATMPs.
Behind the scenes of 3P innovation's Customer Care team

Behind the scenes of 3P innovation's Customer Care team

Picture of Georgia Lewis-Marston Georgia Lewis-Marston: 17 October 2025

This week, I had the chance to sit down with Paul Beard, Operations Director at 3P innovation, to explore what truly distinguishes our Customer Care...

Read More
Filling syringes with spray-dried powders - the how, the why and the benefits.

Filling syringes with spray-dried powders - the how, the why and the benefits.

David Phasey: 15 October 2025

For many therapy developers, the challenge doesn’t start in manufacturing, it begins much earlier in formulation. Once a promising therapy has...

Read More
What does Annex 1 mean for cryovial filling? Insights from 3P innovation.

What does Annex 1 mean for cryovial filling? Insights from 3P innovation.

Charles Pilato: 6 October 2025

The revision of EU GMP Annex 1 has redefined expectations for sterile manufacturing across the life sciences sector and nowhere is this felt more...

Read More